Neural injury following stroke: Are Toll-like receptors the link between the immune system and the CNS?

British Journal of Pharmacology

Volumn 160, Issue 8, 2010, Pages 1872-1888

  Downes, Catherine E ^a   Crack, Peter J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

macrophages; neural inflammation; stroke; T cells; toll like receptors

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; COMPLEMENT; CYTOKINE; FINGOLIMOD; FREE RADICAL; MYELOID DIFFERENTIATION FACTOR 88; PROSTAGLANDIN DERIVATIVE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 8; ANTIINFLAMMATORY AGENT; AUTACOID; NEUROPROTECTIVE AGENT;

APOPTOSIS; ASTROCYTE; BRAIN DAMAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN TISSUE; CELL TYPE; CENTRAL NERVOUS SYSTEM; CHEMOTAXIS; DISEASE EXACERBATION; DOWN REGULATION; ENDOTHELIUM CELL; GLIA; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MICROGLIA; MONOCYTE; NERVE CELL LESION; NERVE REGENERATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STROKE; ANIMAL; DRUG EFFECTS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; NERVE CELL; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; NEURONS; NEUROPROTECTIVE AGENTS; SIGNAL TRANSDUCTION; STROKE; TOLL-LIKE RECEPTORS;

EID: 77954884148     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00864.x     Document Type: Review

References (153)

1. Adhami F, Liao G, Morozov YM, Schloemer A, Schmithorst VJ, Lorenz JN et al. (2006). Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol 169 : 566 583.
2. Allahtavakoli M, Moloudi R, Arababadi MK, Shamsizadeh A, Javanmardi K (2009). Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat. Brain Res 1271 : 121 127.
3. An H, Xu H, Yu Y, Zhang M, Qi R, Yan X et al. (2002). Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-kappaB, ERK and p38 MAPK signal pathways. Immunol Lett 81 : 165 169.
4. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE et al. (2002). Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277 : 15028 15034.
5. Babcock AA, Toft-Hansen H, Owens T (2008). Signaling through MyD88 regulates leukocyte recruitment after brain injury. J Immunol 181 : 6481 6490.
6. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW (1993). Cytotoxicity of microglia. Glia 7 : 111 118.
7. Bejot Y, Osseby GV, Gremeaux V, Durier J, Rouaud O, Moreau T et al. (2009). Changes in risk factors and preventive treatments by stroke subtypes over 20 years: a population-based study. J Neurol Sci 287 : 84 88.
8. Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Segal DM et al. (2005). The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci USA 102 : 10976 10980.
9. Block F, Peters M, Nolden-Koch M (2000). Expression of IL-6 in the ischemic penumbra. Neuroreport 11 : 963 967.
10. Blomgren K, Leist M, Groc L (2007). Pathological apoptosis in the developing brain. Apoptosis 12 : 993 1010.
11. Boonstra A, Rajsbaum R, Holman M, Marques R, Asselin-Paturel C, Pereira JP et al. (2006). Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J Immunol 177 : 7551 7558.
12. Bornstein NM, Aronovich B, Korczyn AD, Shavit S, Michaelson DM, Chapman J (2001). Antibodies to brain antigens following stroke. Neurology 56 : 529 530.
13. Bowman CC, Rasley A, Tranguch SL, Marriott I (2003). Cultured astrocytes express toll-like receptors for bacterial products. Glia 43 : 281 291.
14. Bsibsi M, Persoon-Deen C, Verwer RW, Meeuwsen S, Ravid R, Van Noort JM (2006). Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53 : 688 695.
15. Bredesen DE, Rao RV, Mehlen P (2006). Cell death in the nervous system. Nature 443 : 796 802.
16. Buck BH, Liebeskind DS, Saver JL, Bang OY, Yun SW, Starkman S et al. (2008). Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke 39 : 355 360.
17. Chakravarty S, Herkenham M (2005). Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systematic cytokines. J Neurosci 25 : 1788 1796.
18. Chen Y, Hallenbeck JM, Ruetzler C, Bol D, Thomas K, Berman NE et al. (2003). Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab 23 : 748 755.
19. Choe J, Kelker MS, Wilson IA (2005). Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309 : 581 585.
20. Choi K, Kim J, Kim GW, Choi C (2009). Oxidative stress-induced necrotic cell death via mitochondira-dependent burst of reactive oxygen species. Curr Neurovasc Res 6 : 213 222.
21. Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B (2008). Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 5 : 46.
22. Cooper CL, Davis HL, Morris ML, Efler SM, Adhami MA, Krieg AM et al. (2004). CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. J Clin Immunol 24 : 693 701.
23. Cowell RM, Xu H, Galasso JM, Silverstein FS (2002). Hypoxic-ischemic injury induces macrophage inflammatory protein-1alpha expression in immature rat brain. Stroke 33 : 795 801.
24. Cuadrado E, Ortega L, Hernandez-Guillamon M, Penalba A, Fernandez-Cadenas I, Rosell A et al. (2008). Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release. J Leukoc Biol 84 : 207 214.
25. Dagvadorj J, Naiki Y, Tumurkhuu G, Hassan F, Islam S, Koide N et al. (2008). Interleukin-10 inhibits tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW 264.7 cells through reduced MyD88 expression. Innate Immun 14 : 109 115.
26. Dambinova SA, Khounteev GA, Izykenova GA, Zavolokov IG, Ilyukhina AY, Skoromets AA (2003). Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem 49 : 1752 1762.
27. Dawson DA, Martin D, Hallenbeck JM (1996). Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci Lett 218 : 41 44.
28. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N et al. (2005). Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1 : 112 119.
29. Degterev A, Yuan J (2008). Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 9 : 378 390.
30. Deng L, Wang C, Spencer E, Yang L, Braun A, You J et al. (2000). Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103 : 351 361.
31. Denker SP, Ji S, Dingman A, Lee SY, Derugin N, Wendland MF et al. (2007). Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke. J Neurochem 100 : 893 904.
32. Farina C, Krumbholz M, Giese T, Hartmann G, Aloisi F, Meinl E (2005). Preferential expression and function of Toll-like receptor 3 in human astrocytes. J Neuroimmunol 159 : 12 19.
33. Felger JC, Abe T, Kaunzner UW, Gottfried-Blackmore A, Gal-Toth J, McEwen BS et al. (2010). Brain dendritic cells in ischemic stroke: time course, activation state, and origin. Brain Behav Immun 24 : 724 737.
34. Ferrer I, Friguls B, Dalfo E, Justicia C, Planas AM (2003). Caspase-dependent and caspase-independent signalling of apoptosis in the penumbra following middle cerebral artery occlusion in the adult rat. Neuropathol Appl Neurobiol 29 : 472 481.
35. Fischer U, Arnold M, Nedeltchev K, Schoenenberger RA, Kappeler L, Hollinger P et al. (2006). Impact of comorbidity on ischemic stroke outcome. Acta Neurol Scand 113 : 108 113.
36. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI et al. (2009). Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40 : 2244 2250.
37. Fujimoto M, Takagi Y, Aoki T, Hayase M, Marumo T, Gomi M et al. (2008). Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia. J Cereb Blood Flow Metab 28 : 1674 1685.
38. Garcia JH, Liu KF, Yoshida Y, Lian J, Chen S, del Zoppo GJ (1994). Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 144 : 188 199.
39. Gary DS, Bruce-Keller AJ, Kindy MS, Mattson MP (1998). Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 18 : 1283 1287.
40. Gautam JK, Ashish, Comeau LD, Krueger JK, Smith MF Jr. (2006). Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling. J Biol Chem 281 : 30132 30142.
41. Gee JM, Kalil A, Thullbery M, Becker KJ (2008). Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke. Stroke 39 : 1575 1582.
42. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA et al. (2009). Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40 : 1849 1857.
43. Giulian D, Vaca K (1993). Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke 24 (12 Suppl I84 I90.
44. Globus MY, Busto R, Martinez E, Valdes I, Dietrich WD (1990). Ischemia induces release of glutamate in regions spared from histopathologic damage in the rat. Stroke 21 (11 Suppl III43 III46.
45. Gomariz RP, Gutierrez-Canas I, Arranz A, Carrion M, Juarranz Y, Leceta J et al. (2010). Peptides targeting toll-like receptor signalling pathways for novel immune therapeutics. Curr Pharm Des 16 : 1063 1080.
46. Gottfried-Blackmore A, Kaunzner UW, Idoyaga J, Felger JC, McEwen BS, Bulloch K (2009). Acute in vivo exposure to interferon-{gamma} enables resident brain dendritic cells to become effective antigen presenting cells. Proc Natl Acad Sci USA DOI: 10.1073/pnas.0911509106 [Epub ahead of print].
47. Grauer OM, Molling JW, Bennink E, Toonen LW, Sutmuller RP, Nierkens S et al. (2008). TLR ligands in the local treatment of established intracerebral murine gliomas. J Immunol 181 : 6720 6729.
48. Grilli M, Barbieri I, Basudev H, Brusa R, Casati C, Lozza G et al. (2000). Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci 12 : 2265 2272.
49. Gromadzka G, Zielinska J, Ryglewicz D, Fiszer U, Czlonkowska A (2001). Elevated levels of anti-heat shock protein antibodies in patients with cerebral ischemia. Cerebrovasc Dis 12 : 235 239.
50. Grove M, Plumb M (1993). C/EBP, NF-kappa B, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1 alpha immediate-early gene. Mol Cell Biol 13 : 5276 5289.
51. Guan QH, Pei DS, Liu XM, Wang XT, Xu TL, Zhang GY (2006). Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis. Brain Res 1092 : 36 46.
52. Hartl R, Schurer L, Schmid-Schonbein GW, del Zoppo GJ (1996). Experimental antileukocyte interventions in cerebral ischemia. J Cereb Blood Flow Metab 16 : 1108 1119.
53. Hata R, Gillardon F, Michaelidis TM, Hossmann KA (1999). Targeted disruption of the bcl-2 gene in mice exacerbates focal ischemic brain injury. Metab Brain Dis 14 : 117 124.
54. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T et al. (2002). Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168 : 4531 4537.
55. Hua F, Ma J, Ha T, Kelley J, Williams DL, Kao RL et al. (2008). Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury. J Neuroimmunol 199 : 75 82.
56. Hughes PM, Allegrini PR, Rudin M, Perry VH, Mir AK, Wiessner C (2002). Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 22 : 308 317.
57. Hurn PD, Subramanian S, Parker SM, Afentoulis ME, Kaler LJ, Vandenbark AA et al. (2007). T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab 27 : 1798 1805.
58. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E et al. (2005). TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175 : 4320 4330.
59. Jander S, Kraemer M, Schroeter M, Witte OW, Stoll G (1995). Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab 15 : 42 51.
60. Jayaraman T, Paget A, Shin YS, Li X, Mayer J, Chaudhry H, et al. (2008). TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag 4 : 805 817.
61. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG et al. (2007). Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130 : 1071 1082.
62. Jung DY, Lee H, Jung BY, Ock J, Lee MS, Lee WH et al. (2005). TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J Immunol 174 : 6467 6476.
63. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D (2004a). mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279 : 12542 12550.
64. Kariko K, Weissman D, Welsh FA (2004b). Inhibition of toll-like receptor and cytokine signaling - a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 24 : 1288 1304.
65. Kaur C, Ling EA (2008). Blood brain barrier in hypoxic-ischemic conditions. Curr Neurovasc Res 5 : 71 81.
66. Kilic U, Kilic E, Matter CM, Bassetti CL, Hermann DM (2008 TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration. Neurobiol Dis 31 : 33 40.
67. Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC et al. (2007). Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130 : 906 917.
68. Kirino T (1982). Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239 : 57 69.
69. Laflamme N, Rivest S (2001). Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J 15 : 155 163.
70. Lafon M, Megret F, Lafage M, Prehaud C (2006). The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. J Mol Neurosci 29 : 185 194.
71. Lambertsen KL, Gregersen R, Finsen B (2002). Microglial-macrophage synthesis of tumor necrosis factor after focal cerebral ischemia in mice is strain dependent. J Cereb Blood Flow Metab 22 : 785 797.
72. Lambertsen KL, Clausen BH, Fenger C, Wulf H, Owens T, Dagnaes-Hansen F et al. (2007). Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice. Neuroscience 144 : 934 949.
73. Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH et al. (2009). Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 29 : 1319 1330.
74. Lambertsen KL, Meldgaard M, Ladeby R, Finsen B (2005). A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25 : 119 135.
75. Lehnardt S, Lehmann S, Kaul D, Tschimmel K, Hoffmann O, Cho S et al. (2007). Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol 190 : 28 33.
76. Levraut J, Iwase H, Shao ZH, Vanden Hoek TL, Schumacker PT (2003). Cell death during ischemia: relationship to mitochondrial depolarization and ROS generation. Am J Physiol Heart Circ Physiol 284 : H549 H558.
77. Li S, Strelow A, Fontana EJ, Wesche H (2002). IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci USA 99 : 5567 5572.
78. Li Y, Chopp M, Jiang N, Zhang ZG, Zaloga C (1995). Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke 26 : 1252 1257, discussion 1257-1258.
79. Liesz A, Hagmann S, Zschoche C, Adamek J, Zhou W, Sun L et al. (2009a). The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 40 : 2849 2858.
80. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S et al. (2009b). Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15 : 192 199.
81. Lin L, Gerth AJ, Peng SL (2004). CpG DNA redirects class-switching towards 'Th1-like' Ig isotype production via TLR9 and MyD88. Eur J Immunol 34 : 1483 1487.
82. Liu L, Botos I, Wang Y, Leonard JN, Shiloach J, Segal DM et al. (2008). Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 320 : 379 381.
83. Love S, Barber R, Wilcock GK (2000). Neuronal death in brain infarcts in man. Neuropathol Appl Neurobiol 26 : 55 66.
84. Ma Y, Li J, Chiu I, Wang Y, Sloane JA, Lu J et al. (2006). Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol 175 : 209 215.
85. Macedo L, Pinhal-Enfield G, Alshits V, Elson G, Cronstein BN, Leibovich SJ (2007). Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol 171 : 1774 1788.
86. Macleod MR, O'Collins T, Howells DW, Donnan GA (2004). Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 35 : 1203 1208.
87. Maddahi A, Chen Q, Edvinsson L (2009). Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat. BMC Neurosci 10 : 56.
88. Marsh BJ, Williams-Karnesky RL, Stenzel-Poore MP (2009). Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 158 : 1007 1020.
89. Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J et al. (2001). Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 8 : 679 686.
90. Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 : 394 397.
91. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M et al. (2004). RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 5 : 503 507.
92. Minami M, Kuraishi Y, Yabuuchi K, Yamazaki A, Satoh M (1992). Induction of interleukin-1 beta mRNA in rat brain after transient forebrain ischemia. J Neurochem 58 : 390 392.
93. Mishra BB, Mishra PK, Teale JM (2006). Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J Neuroimmunol 181 : 46 56.
94. Moriguchi T, Kuroyanagi N, Yamaguchi K, Gotoh Y, Irie K, Kano T et al. (1996). A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J Biol Chem 271 : 13675 13679.
95. Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA (2003). Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 140 : 471 476.
96. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA et al. (2006). Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database. Diabetologia 49 : 2859 2865.
97. Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, Mancinelli R et al. (2000). Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164 : 5998 6004.
98. Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, Akira S et al. (2006). Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24 : 801 812.
99. Nishimura M, Naito S (2005). Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull 28 : 886 892.
100. Nishino H, Czurko A, Fukuda A, Hashitani T, Hida H, Karadi Z et al. (1994). Pathophysiological process after transient ischemia of the middle cerebral artery in the rat. Brain Res Bull 35 : 51 56.
101. Nyman T, Stenmark P, Flodin S, Johansson I, Hammarstrom M, Nordlund P (2008). The crystal structure of the human toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J Biol Chem 283 : 11861 11865.
102. O'Collins VE, Donnan GA, Macleod MR, Howells DW (2009). Scope of preclinical testing versus quality control within experiments. Stroke 40 : e497.
103. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD (2006a). Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 26 : 654 665.
104. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A et al. (2006b). Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 176 : 6523 6531.
105. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B et al. (2006). Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439 : 208 211.
106. Ohashi K, Burkart V, Flohe S, Kolb H (2000). Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164 : 558 561.
107. Olson JK, Miller SD (2004). Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173 : 3916 3924.
108. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO (2009). The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458 : 1191 1195.
109. Pelidou SH, Kostulas N, Matusevicius D, Kivisakk P, Kostulas V, Link H (1999). High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases. Eur J Neurol 6 : 437 442.
110. Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W, Fu T et al. (2005). Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 309 : 1380 1384.
111. Petito CK, Feldmann E, Pulsinelli WA, Plum F (1987). Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 37 : 1281 1286.
112. Petry KG, Boiziau C, Dousset V, Brochet B (2007). Magnetic resonance imaging of human brain macrophage infiltration. Neurotherapeutics 4 : 434 442.
113. Pettigrew LC, Kindy MS, Scheff S, Springer JE, Kryscio RJ, Li Y et al. (2008). Focal cerebral ischemia in the TNFalpha-transgenic rat. J Neuroinflammation 5 : 47.
114. Philip M, Benatar M, Fisher M, Savitz SI (2009). Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Stroke 40 : 577 581.
115. Phillips JB, Williams AJ, Adams J, Elliott PJ, Tortella FC (2000). Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke 31 : 1686 1693.
116. Qian Y, Commane M, Ninomiya-Tsuji J, Matsumoto K, Li X (2001). IRAK-mediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NFkappa B. J Biol Chem 276 : 41661 41667.
117. Qiu P, Pan PC, Govind S (1998). A role for the Drosophila Toll/Cactus pathway in larval hematopoiesis. Development 125 : 1909 1920.
118. Reith J, Jorgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL et al. (1996). Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 347 : 422 425.
119. Riazi K, Galic MA, Kuzmiski JB, Ho W, Sharkey KA, Pittman QJ (2008). Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci USA 105 : 17151 17156.
120. Rosenberg GA, Estrada EY, Dencoff JE (1998). Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 : 2189 2195.
121. Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP, Stenzel-Poore MP (2004). Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 35 : 2576 2581.
122. Roth EJ, Lovell L, Harvey RL, Heinemann AW, Semik P, Diaz S (2001). Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke 32 : 523 529.
123. Sairanen T, Szepesi R, Karjalainen-Lindsberg ML, Saksi J, Paetau A, Lindsberg PJ (2009). Neuronal caspase-3 and PARP-1 correlate differentially with apoptosis and necrosis in ischemic human stroke. Acta Neuropathol 118 : 541 552.
124. Samarasinghe R, Tailor P, Tamura T, Kaisho T, Akira S, Ozato K (2006). Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling. J Interferon Cytokine Res 26 : 893 900.
125. Schilling M, Strecker JK, Schabitz WR, Ringelstein EB, Kiefer R (2009). Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 161 : 806 812.
126. Shen H, Tesar BM, Walker WE, Goldstein DR (2008). Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation. J Immunol 181 : 1849 1858.
127. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I et al. (2009). Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 15 : 946 950.
128. Singh AK, Jiang Y (2004). How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology 201 : 197 207.
129. Smith ML, Auer RN, Siesjo BK (1984). The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol 64 : 319 332.
130. Spera PA, Ellison JA, Feuerstein GZ, Barone FC (1998). IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 251 : 189 192.
131. Stevens SL, Ciesielski TM, Marsh BJ, Yang T, Homen DS, Boule JL et al. (2008). Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J Cereb Blood Flow Metab 28 : 1040 1047.
132. Strbian D, Karjalainen-Lindsberg ML, Kovanen PT, Tatlisumak T, Lindsberg PJ (2007). Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. Circulation 116 : 411 418.
133. Strecker JK, Sevimli S, Schilling M, Klocke R, Nikol S, Schneider A et al. (2010). Effects of G-CSF treatment on neutrophil mobilization and neurological outcome after transient focal ischemia. Exp Neurol 222 : 108 113.
134. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T et al. (2002). Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195 : 99 111.
135. Trajkovic V, Vuckovic O, Stosic-Grujicic S, Miljkovic D, Popadic D, Markovic M et al. (2004). Astrocyte-induced regulatory T cells mitigate CNS autoimmunity. Glia 47 : 168 179.
136. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K et al. (1994). NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 153 : 2052 2063.
137. Ueda Y, Kondo M, Kelsoe G (2005). Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med 201 : 1771 1780.
138. Vargas M, Horcajada JP, Obach V, Revilla M, Cervera A, Torres F et al. (2006). Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke 37 : 461 465.
139. Villa P, Triulzi S, Cavalieri B, Di Bitondo R, Bertini R, Barbera S et al. (2007). The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats. Mol Med 13 : 125 133.
140. Wang CD, Chang GD, Lee YK, Chen H (2001). A functional composite cis-element for NF kappa b and RBJ kappa in the rat pregnancy-specific glycoprotein gene. Biol Reprod 65 : 1437 1443.
141. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z (1997). MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7 : 837 847.
142. Weston RM, Jones NM, Jarrott B, Callaway JK (2007). Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury. J Cereb Blood Flow Metab 27 : 100 114.
143. Widmer U, Manogue KR, Cerami A, Sherry B (1993). Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine superfamily of proinflammatory cytokines. J Immunol 150 : 4996 5012.
144. Xing B, Chen H, Zhang M, Zhao D, Jiang R, Liu X et al. (2008). Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke 39 : 2362 2369.
145. Xu D, Komai-Koma M, Liew FY (2005). Expression and function of Toll-like receptor on T cells. Cell Immunol 233 : 85 89.
146. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K et al. (2002). Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 169 : 6668 6672.
147. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H et al. (2003). Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 : 640 643. (Pubitemid 36927946)
148. Yilmaz G, Granger DN (2008). Cell adhesion molecules and ischemic stroke. Neurol Res 30 : 783 793.
149. Yilmaz G, Arumugam TV, Stokes KY, Granger DN (2006). Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113 : 2105 2112.
150. Zhou ML, Shi JX, Hang CH, Zhang FF, Gao J, Yin HX (2007). Expression of toll-like receptor 4 in the brain in a rabbit experimental subarachnoid haemorrhage model. Inflamm Res 56 : 93 97.
151. Ziegler G, Harhausen D, Schepers C, Hoffmann O, Rohr C, Prinz V et al. (2007). TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem Biophys Res Commun 359 : 574 579.
152. Zierath D, Thullbery M, Hadwin J, Gee JM, Savos A, Kalil A et al. (2010). CNS immune responses following experimental stroke. Neurocrit Care 12 : 274 284.
153. del Zoppo GJ, Mabuchi T (2003). Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab 23 : 879 894.